ingentaconnect Trastuzumab: In HER2-Positive Metastatic Gastric Cancer
Links shared publicly online about this topic.
- 716total visits
ingentaconnect Trastuzumab: In HER2-Positive Metastatic Gastric Cancer
View full resource at ingentaconnect.com
Tags: IBD, Cancer, Breast Cancer Medication, Stomach Cancer, Drug, Herceptin, Surgery
Most Recently Shared on November 19, 2010 at 8:23 am By:
Trastuzumab: In HER2-Positive Metastatic Gastric Cancer: (Source: Drugs) http://bit.ly/bdlmG6
Also Shared By:
NICE guidance on trastuzumab for the treatment of HER2-positive metastatic gastric cancer : The Lancet Oncology
thelancet.com — “NICE guidance on trastuzumab for the treatment of HER2-positive metastatic gastric cancer. By - Joanne Holden, Zoe Garrett, Andrew Stevens” View full resource at thelancet.com
Most Recently Shared on January 1, 2011 at 1:06 am By:
[News] NICE guidance on trastuzumab for the treatment of HER2-positive metastatic gastric cancer: On Nov 24, 201... http://bit.ly/dSvOtn
FDA Approves Herceptin For HER2-Positive Metastatic Stomach Cancer
drugs.com — “Herceptin (trastuzumab) is used to treat HER2-overexpressing breast cancer and metastatic gastric cancer. Includes Herceptin side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on October 21, 2010 at 3:04 am By:
FDA Approves Herceptin For HER2-Positive Metastatic Stomach Cancer - http://bit.ly/bPZHjj
Advertisement
Drugs and Devices OW
@Drugs_Devices
Trastuzumab: In HER2-Positive Metastatic Gastric Cancer: (Source: Drugs) http://bit.ly/bdlmG6
1 year ago...